# Cross-Phase Verification Document

> **Created:** 2026-05-12
> **Purpose:** Ensure consistency, identify gaps, verify dependencies, and establish exit criteria across all development phases
> **Status:** Initial Analysis

---

## Executive Summary

This document provides cross-phase coordination and verification for the one4all development roadmap. It identifies consistencies, gaps, conflicts, and verifies that dependencies are correctly structured across all 6 phases.

**Overall Assessment:** The phases are generally well-structured with clear sequential dependencies. Several inconsistencies and gaps have been identified that require resolution before Phase 1 begins.

---

## Phase Dependency Graph

```
Phase 0: Specification Freeze (Foundation)
    |
    v
Phase 1: Kernel Core (TypeScript + Mocks)
    |
    v
Phase 2: Adapter Layer + CLI (Real LLM Integration)
    |
    v
Phase 3: Investment War Room MVP (Domain Implementation)
    |
    v
Phase 4: MCP Interface (Integration Layer)
    |
    v
Phase 5: Enhanced + Second Domain (Architecture Validation)
```

**Verification:** Dependencies are correctly structured as a linear pipeline. Each phase builds upon the previous one.

---

## Exit Criteria Verification

| Phase | Exit Criteria | Clear? | Verifiable? |
|-------|---------------|--------|-------------|
| 0 | All spec documents complete, reviewed, consistent | Yes | Yes - checklist exists |
| 1 | Full mission runs with mock data, zero real LLM calls | Yes | Yes - testable |
| 2 | Single adapter works with real LLM, CLI functional | Yes | Yes - testable |
| 3 | Full investment analysis works on benchmark stocks | Yes | Yes - benchmark stocks defined |
| 4 | Claude Code can use one4all tools seamlessly | Yes | Yes - integration testable |
| 5 | System supports multiple domains with zero kernel changes | Yes | Yes - architecture validation |

**Status:** All phases have clear, verifiable exit criteria.

---

## Consistency Analysis

### 1. Timeline Consistency

| Phase | Duration | Notes |
|-------|----------|-------|
| 0 | 2 weeks | Documentation only |
| 1 | 2 weeks | TypeScript foundation |
| 2 | 2 weeks | Adapters + CLI |
| 3 | 4 weeks | MVP (double duration) |
| 4 | 2 weeks | MCP interface |
| 5 | 2 weeks | Enhanced + second domain |

**Issue:** Phase 3 is 4 weeks while all others are 2 weeks. This should be explicitly justified in the roadmap.

**Recommendation:** Add justification for Phase 3's extended duration (agent development, integration complexity, validation on benchmarks).

### 2. Component Naming Consistency

| Component | Phase 1 | Phase 2 | Phase 3 | Consistent? |
|-----------|---------|---------|---------|-------------|
| Evidence handling | evidence-controller | - | evidence-pack-builder | Partial - needs reconciliation |
| Debate system | debate-controller | - | debate-controller | Yes |
| Journal | journal-writer | - | - (mentioned in output) | Yes |
| Constitution | constitution-enforcer | - | - (mentioned in testing) | Yes |
| CLI | - | CLI package | - | N/A (new in P2) |

**Issue:** "Evidence pack builder" (P3) vs "evidence-controller" (P1). These should be consistently named or clearly distinguished.

### 3. Agent Count Consistency

- Phase 3 lists **12 agents** (2 researchers, 8 analysts, 2 synthesizers)
- Phase 4 mentions "8+ MCP tools"
- Phase 4 text mentions "8+ agents" in success criteria

**Issue:** Agent count varies between mentions.

**Clarification Needed:** Define the exact agent roster and maintain consistent count across documentation.

---

## Identified Gaps

### Critical Gaps

1. **Mission State Machine Definition**
   - **Issue:** Phase 1 requires implementing the state machine, but Phase 0's MISSION_LIFECYCLE.md must exist first
   - **Impact:** Cannot start Phase 1 without complete state specification
   - **Verification:** Check MISSION_LIFECYCLE.md exists in Phase 0 deliverables

2. **Agent Output Schemas**
   - **Issue:** Phase 1's Output Validator requires schemas from AGENT_MODEL.md
   - **Impact:** Cannot implement validation without schemas
   - **Verification:** AGENT_MODEL.md must include Zod schemas for each agent

3. **Constitution Rules**
   - **Issue:** Phase 1 implements constitution enforcer, Phase 3 references enforcement
   - **Impact:** Rules must be fully specified in Phase 0
   - **Verification:** COMPANY_CONSTITUTION.md must include all investment-war-room rules

4. **Evidence Pack Structure**
   - **Issue:** Phase 3's evidence pack builder needs structure from EVIDENCE_STANDARD.md
   - **Impact:** Cannot implement without structure definition
   - **Verification:** EVIDENCE_STANDARD.md must define pack structure

### Medium Priority Gaps

5. **Python Quant Module**
   - **Issue:** Introduced in Phase 2, not mentioned in Phase 1 architecture
   - **Impact:** Architecture needs to account for Python subprocess integration
   - **Recommendation:** Add Python integration to ARCHITECTURE.md

6. **CLI Package Missing from Phase 1**
   - **Issue:** CLI package appears in Phase 2, not in Phase 1 structure
   - **Impact:** Minor - CLI is appropriately phased
   - **Status:** Acceptable as Phase 2 deliverable

7. **Evidence Controller vs Evidence Pack Builder**
   - **Issue:** Phase 1 mentions evidence-controller, Phase 3 mentions evidence-pack-builder
   - **Impact:** Potential confusion about component responsibility
   - **Recommendation:** Clarify or consolidate terminology

8. **Health Monitor Placement**
   - **Issue:** Listed in both Phase 1 (observability) and Phase 2 (health check specific)
   - **Impact:** Duplicate responsibility possible
   - **Recommendation:** Phase 1 creates base, Phase 2 extends for real backends

---

## Conflicts and Contradictions

### 1. Timeline Misalignment
- **Conflict:** ROADMAP.md shows Phase 3 as "Week 7-10" (4 weeks), but other phases are 2 weeks
- **Resolution:** Document justification for Phase 3's extended duration

### 2. MCP Tool Count
- **Conflict:** Phase 4 says "8+ MCP tools" but lists 14 distinct tools
- **Resolution:** Change to "14 MCP tools" or clarify what "8+" refers to

### 3. Zero Kernel Changes Claim
- **Issue:** Phase 5 claims "zero kernel changes" for second domain
- **Validation Needed:** Domain template must be comprehensive enough to support ANY domain
- **Verification:** Review DOMAIN_TEMPLATE.md for completeness

---

## Cross-Phase Dependencies

### Phase 0 -> Phase 1
| Phase 0 Deliverable | Phase 1 Dependency | Critical? |
|---------------------|-------------------|-----------|
| PROJECT_CHARTER.md | Context for development | Yes |
| ARCHITECTURE.md | Package structure implementation | Yes |
| MISSION_LIFECYCLE.md | State machine implementation | Yes |
| AGENT_MODEL.md | Output validator schemas | Yes |
| DEBATE_PROTOCOL.md | Debate controller logic | Yes |
| COMPANY_CONSTITUTION.md | Constitution enforcer | Yes |
| JOURNAL_SCHEMA.md | Journal writer schema | Yes |
| EVIDENCE_STANDARD.md | Evidence pack structure | Yes |
| DOMAIN_TEMPLATE.md | Domain structure | Yes |

### Phase 1 -> Phase 2
| Phase 1 Deliverable | Phase 2 Dependency | Critical? |
|---------------------|-------------------|-----------|
| Mock adapters | Real adapter interface | Yes |
| State machine | CLI mission commands | Yes |
| Journal writer | CLI journal commands | Yes |
| Observability layer | CLI log/audit commands | Yes |
| Health monitor (base) | Extended health checks | Yes |

### Phase 2 -> Phase 3
| Phase 2 Deliverable | Phase 3 Dependency | Critical? |
|---------------------|-------------------|-----------|
| Real adapters | Agent execution | Yes |
| Python quant | Valuation calculations | Yes |
| CLI | Testing interface | No (can use direct API) |
| Fallback chain | Agent reliability | Yes |

### Phase 3 -> Phase 4
| Phase 3 Deliverable | Phase 4 Dependency | Critical? |
|---------------------|-------------------|-----------|
| Working mission system | MCP tool wrappers | Yes |
| Agent roster | list_agents tool | Yes |
| Journal system | journal tools | Yes |
| Observability | trace/scorecard tools | Yes |

### Phase 4 -> Phase 5
| Phase 4 Deliverable | Phase 5 Dependency | Critical? |
|---------------------|-------------------|-----------|
| MCP tools | Enhanced interface | No (can work directly) |
| Documentation | Domain creation guide | Yes |

---

## Verification Checklist by Phase

### Phase 0 Verification
- [ ] All 9 documents created
- [ ] MISSION_LIFECYCLE.md has complete state machine diagram
- [ ] AGENT_MODEL.md has Zod schemas for all 12 agents
- [ ] COMPANY_CONSTITUTION.md has all enforcement rules
- [ ] EVIDENCE_STANDARD.md defines evidence pack structure
- [ ] DOMAIN_TEMPLATE.md is complete for ANY domain
- [ ] All documents cross-referenced consistently
- [ ] No undefined terms or references

### Phase 1 Verification
- [ ] Package structure matches ARCHITECTURE.md
- [ ] State machine implements all MISSION_LIFECYCLE states
- [ ] Mock adapters match real adapter interfaces (planned for P2)
- [ ] Journal schema matches JOURNAL_SCHEMA.md
- [ ] Constitution rules load correctly from YAML
- [ ] All tests use mocks (zero real API calls)
- [ ] Full mission runs DRAFT -> JOURNALED

### Phase 2 Verification
- [ ] Each real adapter implements mock interface
- [ ] Fallback chain activates correctly
- [ ] Health check detects all backends
- [ ] CLI commands work for all major operations
- [ ] Python quant module integrates correctly
- [ ] Cost tracking works
- [ ] At least one real adapter completes successfully

### Phase 3 Verification
- [ ] All 12 agents defined and tested
- [ ] Evidence pack builder uses EVIDENCE_STANDARD structure
- [ ] Debate system implements DEBATE_PROTOCOL
- [ ] Benchmark stocks (APP, MCS, HMPRO, ACG, CPALL, SCGD) run successfully
- [ ] Journal entries created automatically
- [ ] Constitution rules enforced
- [ ] Output matches owner's framework

### Phase 4 Verification
- [ ] All 14 MCP tools implemented
- [ ] Claude Code can call tools successfully
- [ ] Tools handle errors gracefully
- [ ] Long-running missions work
- [ ] Documentation is complete

### Phase 5 Verification
- [ ] Enhanced debate protocol fully implemented
- [ ] Evidence request loop works
- [ ] Disagreement tracker functional
- [ ] Second domain created and tested
- [ ] Zero changes to kernel for second domain
- [ ] Domain switching works
- [ ] Cross-domain queries work correctly

---

## Architecture Validation Questions

### For Phase 0 Reviewers
1. Does MISSION_LIFECYCLE.md cover all error states?
2. Are all agent output schemas in AGENT_MODEL.md complete?
3. Does COMPANY_CONSTITUTION.md cover all enforcement scenarios?
4. Is EVIDENCE_STANDARD.md sufficient for Phase 3's evidence pack builder?
5. Is DOMAIN_TEMPLATE.md comprehensive enough for ANY domain?

### For Phase 1-2 Transition
1. Do mock adapters match real adapter requirements?
2. Is the health monitor extensible for new backends?
3. Is CLI command structure complete for all operations?

### For Phase 2-3 Transition
1. Are all required adapters working?
2. Is Python quant module complete for all valuation methods?
3. Is fallback chain sufficient for production?

### For Phase 3-4 Transition
1. Is the mission system stable enough for MCP exposure?
2. Are all required observability endpoints available?
3. Is journal query interface complete?

### For Phase 4-5 Transition
1. Is MCP interface stable?
2. Is domain template actually sufficient for new domains?
3. Can kernel truly remain unchanged?

---

## Risk Register

| Risk | Phase | Impact | Mitigation |
|------|-------|--------|------------|
| Incomplete Phase 0 specs | 0-1 | High | Thorough review before Phase 1 |
| State machine ambiguity | 1-2 | High | Formal specification in Phase 0 |
| Adapter interface mismatch | 1-2 | Medium | Interface defined in Phase 0 |
| Agent schema gaps | 1-3 | High | All schemas in Phase 0 |
| Constitution rule gaps | 1-3 | High | All rules in Phase 0 |
| Evidence pack structure | 2-3 | Medium | Defined in Phase 0 |
| Python integration issues | 2-3 | Medium | Plan subprocess API in Phase 1 |
| Domain template incomplete | 0-5 | High | Validate template before Phase 5 |

---

## Recommendations

### Before Phase 1 Starts
1. Complete Phase 0 with all 9 documents
2. Conduct formal review of all Phase 0 documents
3. Verify MISSION_LIFECYCLE.md has complete state machine
4. Verify AGENT_MODEL.md has complete Zod schemas
5. Verify DOMAIN_TEMPLATE.md is comprehensive

### During Phase 1
1. Maintain strict mock-only testing
2. Document all adapter interface requirements
3. Plan Python integration architecture

### During Phase 2
1. Test each adapter thoroughly before integration
2. Validate CLI commands cover all use cases
3. Test fallback chain extensively

### During Phase 3
1. Use benchmark stocks for validation
2. Test all 12 agents individually
3. Validate constitution enforcement

### During Phase 4
1. Test MCP tools with Claude Code early
2. Document all tool behaviors
3. Handle error cases gracefully

### During Phase 5
1. Validate "zero kernel changes" claim
2. Test domain switching thoroughly
3. Document domain creation process

---

## Handoff Checklist Template

Each phase should create a handoff document containing:

### Phase N -> Phase N+1 Handoff

**Completed Deliverables:**
- [ ] All deliverables from phase plan completed
- [ ] All tests passing
- [ ] Exit criteria met

**Documentation:**
- [ ] API documentation
- [ ] Architecture decisions recorded
- [ ] Known issues documented
- [ ] Next phase prerequisites listed

**Artifacts:**
- [ ] Code repository tagged
- [ ] Test fixtures available
- [ ] Example outputs saved
- [ ] Configuration files documented

**For Next Phase:**
- [ ] Clear starting point
- [ ] Known limitations
- [ ] Recommended priorities
- [ ] Contact for questions

---

## Conclusion

The one4all development roadmap is well-structured with clear sequential dependencies. The primary concerns are:

1. **Phase 0 completeness** - All specification documents must be truly complete before Phase 1
2. **Schema definitions** - AGENT_MODEL.md must have complete, validated schemas
3. **Domain template** - Must be comprehensive to support Phase 5's goals
4. **Consistency** - Minor terminology issues need resolution

**Overall Assessment:** Ready to proceed with Phase 0, pending formal review of this verification document.

---

*This document should be updated as phases progress and new information emerges.*
